Immunosuppression After Repeat Keratoplasty

NCT04147390 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Keratopathy

Interventions

DRUG: prescribe topical 0.03 % tacrolimus
DRUG: prescribe mycophenolate mofetil(MMF)

Sponsor

Shahid Beheshti University of Medical Sciences